Dioxaphetyl butyrate
A synthetic opioid analgesic
| Dioxaphetyl butyrate | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Dioxaphetyl butyrate is a synthetic opioid analgesic that was developed in the mid-20th century. It is known for its potent analgesic properties and is used in the management of moderate to severe pain.
Chemical Structure
Dioxaphetyl butyrate is chemically classified as an opioid, which means it is a compound that binds to opioid receptors in the central nervous system. The chemical structure of Dioxaphetyl butyrate includes a phenyl group and a butyrate ester, which contribute to its pharmacological activity.
Pharmacology
Dioxaphetyl butyrate acts primarily as an agonist at the mu-opioid receptor, which is responsible for its analgesic effects. By binding to these receptors, it inhibits the transmission of pain signals in the nervous system. This mechanism is similar to that of other opioids, such as morphine and fentanyl.
Medical Uses
Dioxaphetyl butyrate is used in the treatment of moderate to severe pain, particularly in cases where other analgesics are ineffective. It is important to note that, like other opioids, it has the potential for abuse and dependence, and its use is typically restricted to situations where alternative treatments are not suitable.
Side Effects
Common side effects of Dioxaphetyl butyrate include nausea, vomiting, constipation, and drowsiness. More serious side effects can include respiratory depression, which is a potentially life-threatening condition where breathing becomes inadequate.
Regulation
Due to its potential for abuse, Dioxaphetyl butyrate is classified as a controlled substance in many countries. Its distribution and use are strictly regulated to prevent misuse and addiction.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD